The largest database of trusted experimental protocols

Fg 4592

Manufactured by Merck Group
Sourced in United Kingdom, United States

FG-4592 is a laboratory equipment product developed by Merck Group. It is designed for general laboratory use. The core function of FG-4592 is to perform specific laboratory tasks, but a detailed description cannot be provided while maintaining an unbiased and factual approach.

Automatically generated - may contain errors

4 protocols using fg 4592

1

Dosage Guidance for FG-4592 in Corneal Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To provide guidance for the dosage of FG-4592 (Sigma, St. Louis, MO), a human corneal endothelial cell line24 (link) (HCEC) was used. Sonication was not considered appropriate for cells attached to a tissue culture plate, so tBHP (tert-Butyl hydroperoxide) was applied to damage cells. HCEC were seeded in 12-well plates at 2 × 105 (link) cells/well in 1 ml Opti-MEM with 10% fetal calf serum (FBS). At approximately 60% confluence, the cells were changed to Opti-MEM with 0.5% FBS for 6 hours. The medium was then changed to include FG-4592 at 0, 1, 5, 10, 50 and 100 μM diluted in DMEM from a 50mM stock dissolved in dimethyl sulfoxide (DMSO). After maintaining for 2 hours, tertiary butyl hydroperoxide (tBHP) was added to the cells at the concentration of 1mM for another 2 hours.
+ Open protocol
+ Expand
2

Cell Culture and Characterization Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
DLD-1, HCT-116, SW-480, A549 (American Type Culture Collection) and AD293 cells (Agilent, Santa Clara, CA, USA) were cultured and grown in DMEM supplemented with 10% heat-inactivated foetal bovine serum (Thermo, Abingdon, UK). Human vein endothelial cells were cultured in EGM-2 complete medium (Lonza, Walkersville, MD, USA). Short tandem repeat profiling (Source Bioscience, Nottingham, UK) and mycoplasma testing (Lonza, Walkersville, MD, USA) were performed routinely. MG-132, FG-4592, 5,6-Dichloro-1-β-D-ribofuranosyl-benzimidazole (DRB) were purchased from Sigma Aldrich (Gillingham, UK), VH298 from Abcam (Cambridge, UK), Pimonidazole from Hypoxyprobe (Burlington, MA, USA) and 5-ethynyl-2-uridine (5’EU) from Jena Bioscience (Jena, Germany).
+ Open protocol
+ Expand
3

Evaluation of Bicalutamide's Cellular Effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bicalutamide (Bic), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), Dulbecco’s modified Eagle medium (DMEM), tetramethyl ethylene diamine (TEMED) and FG4592 were provided by Sigma-Aldrich (St. Louis, MO, USA). The enhanced chemiluminescence (ECL) system was a product of Merck Millipore (Billerica, MA, USA). The PRO-PREP Protein Extraction Solution was provided by iNtRON Biotech. (Kyungki-Do, Korea). JC-1, dihydroethidium (DHE) and dichlorodihydrofluorescein diacetate (DCFDA) were provided by Millipore Sigma (St. Louis, MO, USA). The 2% charcoal-containing fetal bovine serum (FBS) was provided by GeneTex (Irvine, CA, USA).
+ Open protocol
+ Expand
4

Culturing and Treating Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
MDA-MB-231, MDA-MB-436, Hs578T, BT474, and 293T cells were cultured in DMEM (Gibco 11965118) supplemented with 10% FBS and 1% penicillin–streptomycin. T47D, HCC3153, HCC70, and MDA-MB-468 cells were cultured in 10% FBS, 1% penicillin–streptomycin RPMI 1640 (Gibco, 11875093). Normal breast epithelial cells MCF10A were cultured in Mammary Epithelial Growth Medium (Lonza CC-3151) containing SingleQuots Supplements (Lonza CC-4136). SUM149 cells were cultured in HuMEC Ready Medium (Gibco, 12752–010). HCC3153 cells were obtained from the cell repository of the Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center (Dallas, TX). Mycoplasma detection was routinely performed using the MycoAlert Detection Kit (Lonza, LT07–218). All cells were maintained at 37 °C in a humidified atmosphere containing 5% CO2. For hypoxia treatment, cells were maintained for indicated time in the hypoxia chamber (Coy Laboratory Products). DMOG (D1070–1g, 1 μM) was from Frontier Scientific, DFO (D9533–1G, 200 mM) and FG4592 (D9533–1G, 200 mM) was from Sigma. For drug treatment, cells were treated with drugs for 12 hours.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!